Group One Trading, L.P. Adverum Biotechnologies, Inc. Transaction History

Group One Trading, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.26 $12,230 - $20,546	16,307 New	16,307 $12,000
Q1 2023 May 12, 2023	BUY	$0.62 - $0.85 $13,375 - $18,337	21,574 New	21,574 $15,000
Q2 2020 Aug 13, 2020	SELL	$8.53 - $25.64 $114,267 - $343,473	-13,396 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$7.98 - $16.32 $678,116 - $1.39 Million	-84,977 Reduced 86.38%	13,396 $131,000
Q4 2019 Feb 10, 2020	BUY	$5.12 - $12.22 $124,139 - $296,286	24,246 Added 32.71%	98,373 $1.13 Million
Q3 2019 Nov 12, 2019	BUY	$5.24 - $15.89 $265,856 - $806,195	50,736 Added 216.9%	74,127 $404,000
Q2 2019 Aug 09, 2019	BUY	$5.1 - $11.89 $119,294 - $278,118	23,391 New	23,391 $278,000
Q1 2019 May 13, 2019	SELL	$3.03 - $6.02 $1,893 - $3,762	-625 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$2.87 - $5.92 $1,793 - $3,700	625 New	625 $2,000
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $95,442 - $124,255	-18,008 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.65 - $7.95 $15,446 - $33,644	4,232 Added 30.72%	18,008 $104,000
Q4 2017 Feb 09, 2018	BUY	$2.85 - $3.95 $22,515 - $31,205	7,900 Added 134.45%	13,776 $48,000
Q3 2017 Nov 15, 2017	SELL	$2.45 - $3.65 $2,496 - $3,719	-1,019 Reduced 14.78%	5,876 $21,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,895	6,895 $17,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.